1. Home
  2. PTRN vs LGND Comparison

PTRN vs LGND Comparison

Compare PTRN & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pattern Group Inc.

PTRN

Pattern Group Inc.

N/A

Current Price

$22.81

Market Cap

5.0B

ML Signal

N/A

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$293.98

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTRN
LGND
Founded
2013
1987
Country
United States
United States
Employees
2300
68
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
3.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PTRN
LGND
Price
$22.81
$293.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
7
Target Price
$19.56
$256.29
AVG Volume (30 Days)
2.2M
297.8K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$27.89
$1.25
Revenue Next Year
$22.19
$19.41
P/E Ratio
N/A
$76.27
Revenue Growth
N/A
N/A
52 Week Low
$9.19
$131.67
52 Week High
$29.80
$326.63

Technical Indicators

Market Signals
Indicator
PTRN
LGND
Relative Strength Index (RSI) 37.01 53.53
Support Level $10.48 $290.20
Resistance Level $29.80 $326.63
Average True Range (ATR) 1.45 10.65
MACD -1.04 -3.64
Stochastic Oscillator 3.49 23.41

Price Performance

Historical Comparison
PTRN
LGND

About PTRN Pattern Group Inc.

Pattern Group Inc is an e-commerce accelerator that uses its technology platform, data science, and a team of experts to drive growth for brands. The Company acquires inventory from brand partners to sell to consumers, enabling full control over content, pricing, logistics, and customer service. Brand partners that contract with the Company operate in various industries, including health and wellness, beauty and personal care, home and lifestyle, pet, sports and outdoors, and consumer electronics. The Company mainly derives its revenue in the United States by selling products to customers via online marketplaces. The company genrates majority of revenue from the US.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: